Cargando…
Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT
Nonsurgical periodontal therapy with adjunctive use of systemic antimicrobials (for 7–14 days) showed improved clinical, microbiological and immunological results over the mechanical protocol alone. Considering the increasing risk for antimicrobial resistance with longer antibiotic regimes, it is im...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530673/ https://www.ncbi.nlm.nih.gov/pubmed/33004857 http://dx.doi.org/10.1038/s41598-020-73054-8 |
_version_ | 1783589613887029248 |
---|---|
author | Cosgarea, Raluca Eick, S. Jepsen, S. Arweiler, N. B. Juncar, R. Tristiu, R. Salvi, G. E. Heumann, C. Sculean, A. |
author_facet | Cosgarea, Raluca Eick, S. Jepsen, S. Arweiler, N. B. Juncar, R. Tristiu, R. Salvi, G. E. Heumann, C. Sculean, A. |
author_sort | Cosgarea, Raluca |
collection | PubMed |
description | Nonsurgical periodontal therapy with adjunctive use of systemic antimicrobials (for 7–14 days) showed improved clinical, microbiological and immunological results over the mechanical protocol alone. Considering the increasing risk for antimicrobial resistance with longer antibiotic regimes, it is important to establish the optimal antibiotic protocol with a maximum antimicrobial benefit and minimum risk for adverse effects. The aim of the study was to evaluate the microbiological and inflammatory outcomes 12-months after a 3-/7-day systemic antibiotic protocol [amoxicillin (AMX) + metronidazole (MET)] adjunctive to subgingival debridement in severe periodontitis compared to mechanical treatment alone. From the initially treated 102 patients, 75 subjects (Placebo group: n = 26; 3-day AMX + MET group: n = 24; 7-day AMX + MET group: n = 25) completed the 12-month examination. Clinical parameters, eight periodontal pathogens and inflammatory markers were determined at baseline and 3-, 6-, 12-months after therapy using real-time PCR and ELISA respectively. After 6 months, several periodontopathogens were significantly more reduced in the two antibiotic groups compared to placebo (p < 0.05). After 1 year, both antibiotic protocols showed significant reductions and detection of the keystone pathogen P. gingivalis compared to placebo. Antibiotic protocols, smoking, disease severity, baseline-BOP, -CAL and -IL-1β, as well as detection of T. denticola at 12-months significantly influenced the residual number of deep sites. The present data indicate that the systemic use of both short and longer antibiotic protocols (AMX + MET) adjunctive to nonsurgical periodontal therapy lead to higher microbiological improvements compared to subgingival debridement alone. The two investigated antibiotic protocols led to comparable microbiological and inflammatory results. |
format | Online Article Text |
id | pubmed-7530673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75306732020-10-02 Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT Cosgarea, Raluca Eick, S. Jepsen, S. Arweiler, N. B. Juncar, R. Tristiu, R. Salvi, G. E. Heumann, C. Sculean, A. Sci Rep Article Nonsurgical periodontal therapy with adjunctive use of systemic antimicrobials (for 7–14 days) showed improved clinical, microbiological and immunological results over the mechanical protocol alone. Considering the increasing risk for antimicrobial resistance with longer antibiotic regimes, it is important to establish the optimal antibiotic protocol with a maximum antimicrobial benefit and minimum risk for adverse effects. The aim of the study was to evaluate the microbiological and inflammatory outcomes 12-months after a 3-/7-day systemic antibiotic protocol [amoxicillin (AMX) + metronidazole (MET)] adjunctive to subgingival debridement in severe periodontitis compared to mechanical treatment alone. From the initially treated 102 patients, 75 subjects (Placebo group: n = 26; 3-day AMX + MET group: n = 24; 7-day AMX + MET group: n = 25) completed the 12-month examination. Clinical parameters, eight periodontal pathogens and inflammatory markers were determined at baseline and 3-, 6-, 12-months after therapy using real-time PCR and ELISA respectively. After 6 months, several periodontopathogens were significantly more reduced in the two antibiotic groups compared to placebo (p < 0.05). After 1 year, both antibiotic protocols showed significant reductions and detection of the keystone pathogen P. gingivalis compared to placebo. Antibiotic protocols, smoking, disease severity, baseline-BOP, -CAL and -IL-1β, as well as detection of T. denticola at 12-months significantly influenced the residual number of deep sites. The present data indicate that the systemic use of both short and longer antibiotic protocols (AMX + MET) adjunctive to nonsurgical periodontal therapy lead to higher microbiological improvements compared to subgingival debridement alone. The two investigated antibiotic protocols led to comparable microbiological and inflammatory results. Nature Publishing Group UK 2020-10-01 /pmc/articles/PMC7530673/ /pubmed/33004857 http://dx.doi.org/10.1038/s41598-020-73054-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Cosgarea, Raluca Eick, S. Jepsen, S. Arweiler, N. B. Juncar, R. Tristiu, R. Salvi, G. E. Heumann, C. Sculean, A. Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT |
title | Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT |
title_full | Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT |
title_fullStr | Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT |
title_full_unstemmed | Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT |
title_short | Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT |
title_sort | microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an rct |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530673/ https://www.ncbi.nlm.nih.gov/pubmed/33004857 http://dx.doi.org/10.1038/s41598-020-73054-8 |
work_keys_str_mv | AT cosgarearaluca microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct AT eicks microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct AT jepsens microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct AT arweilernb microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct AT juncarr microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct AT tristiur microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct AT salvige microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct AT heumannc microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct AT sculeana microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct |